SYNTHESIS OF NEW 6-[4-(2-FLUOROPHENYLPIPERAZINE-1-YL)]-3(2H)-PYRIDAZINONE-2-ACETHYL-2-(SUBSTITUTEDBENZAL)HYDRAZONE DERIVATIVES AND EVULATION OF THEIR CYTOTOXIC EFFECTS IN LIVER AND COLON CANCER CELL LINES
dc.authorid | basak, nese/0000-0001-5566-8321 | |
dc.authorid | Ozdemir, Zenyep/0000-0003-4559-2305 | |
dc.authorwosid | basak, nese/ABH-5495-2020 | |
dc.authorwosid | Ozdemir, Zenyep/AAJ-6384-2020 | |
dc.contributor.author | Ozdemir, Zeynep | |
dc.contributor.author | Basak-Turkmen, Nese | |
dc.contributor.author | Ayhan, Idris | |
dc.contributor.author | Ciftci, Osman | |
dc.contributor.author | Uysal, Mehtap | |
dc.date.accessioned | 2024-08-04T20:45:43Z | |
dc.date.available | 2024-08-04T20:45:43Z | |
dc.date.issued | 2019 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | In this study, seven new 3(2H)-pyridazinone derivatives expected to show cytotoxic activity in liver and colon cancer cell lines were synthesized. Their structures were confirmed by the IR, H-1-NMR, C-13-NMR spectra and elementary analyses. Compunds V-1-V-7 were tested on HEP3B (liver cancer) and HTC116 (colon cancer) cell lines for cytotoxicity by using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] proliferation assay. Human fibroblast cells were used as safety control in these tests. 6-[4-(2-Fluorophenyl)piperazine-1-yl]-3(2H)-pyridazinone-2-acetyl-2-(2-chlorobenzal) hydrazone (compound V-3) was the most active agent with respect to HEP3B and HTC116 cell lines. | en_US |
dc.identifier.doi | 10.1007/s11094-019-01927-y | |
dc.identifier.endpage | 929 | en_US |
dc.identifier.issn | 0091-150X | |
dc.identifier.issn | 1573-9031 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.scopus | 2-s2.0-85061507978 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 923 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s11094-019-01927-y | |
dc.identifier.uri | https://hdl.handle.net/11616/98655 | |
dc.identifier.volume | 52 | en_US |
dc.identifier.wos | WOS:000461018000008 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.relation.ispartof | Pharmaceutical Chemistry Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | pyridazinone | en_US |
dc.subject | cytotoxicity | en_US |
dc.subject | liver cancer | en_US |
dc.subject | colon cancer | en_US |
dc.title | SYNTHESIS OF NEW 6-[4-(2-FLUOROPHENYLPIPERAZINE-1-YL)]-3(2H)-PYRIDAZINONE-2-ACETHYL-2-(SUBSTITUTEDBENZAL)HYDRAZONE DERIVATIVES AND EVULATION OF THEIR CYTOTOXIC EFFECTS IN LIVER AND COLON CANCER CELL LINES | en_US |
dc.type | Article | en_US |